Anaxomics maps have been presented in the cover page of the November issue of Nature Chemical Biology

The Pathway to Discovery

Anaxomics provides biopharmaceutical companies with the most advanced Systems Biology Technologies to help you improve your Drug Discovery and Drug Reprofiling research.

We work in the following domains:

  • puntoFully understand complex Mechanism of Action of drugs and combinations. learn more...
  • puntoEarly profiling of safety issues and off-target effects. learn more...
  • puntoFinding new indications for existing drugs (drug reprofiling or repurposing). learn more...
  • puntoIn/Out license and investment evaluations (for partnering biopharmas and investors). learn more...
  • puntoRequired regulatory Predictive Medicine studies. learn more...
  • puntoSolutions for Nutraceuticals and Cosmetics companies learn more...


We are committed to the discovery and development of new and better drugs to improve human health. Our goal is to help the biopharma industry to maximize the value of their discovery and clinical development by leveraging the potential indications of all the compounds on their pipeline, and by identifying and minimizing in their potential safety risks.

We are also establishing long-term partnerships with our clients to:

  • puntoIdentify new drug targets
  • puntoIdentify new Biomarkers
  • puntoIdentify molecular basis of mechanisms of action
punto cuadradoLearn more about Integrated Solutions


Anaxomics Therapeutic Performance Mapping System©:

is a proprietary technology developed by Anaxomics that allows Biopharma companies to maximize the value of their pipeline by analyzing the safety profile of their drugs in the pipeline, and by finding new indications for known molecules



Anaxomics imagotipoNews & Updates
  • puntoAnaxomics to be present in the Bio-Europe Spring Conference in Barcelona Learn more...
  • puntoAnaxomics in the Bio International Convention in ChicagoLearn more...
  • puntoAnaxomics has been awarded 5 ner competitive research grants from the european union's seventh framework programme FP7-HEALTH-2013Learn more...
  • puntoAnaxomics awarded by Red Herring as one of the 100 most innovative European companies. Learn more...
  • puntoNew publications added recently related to the use of systems biology in drug discovery Learn more...

Icon Pdf Download our Electronic Brochure

Anaxomics imagotipoAnaxomics launches the Global Collaborative Initiative for Drug Reprofiling. We are supporting biopharma companies to analyze and identify new indications for drugs already in the pipeline from
a rational and highly predictive perspective, on a fee-for-service, or risk-sharing basis.
punto cuadradoLearn more about Global Drug Reprofiling


Anaxomics imagotipoAnaxomics is looking for partners for competitive public R&D multinational projects, both in Europe and North-America.
punto cuadradoLearn more about Research and Development


Anaxomics imagotipoLearn how Anaxomics can help Nutraceuticals and Cosmetics companies to comply with
regulatory requirements and sustain scientific claims before regulatory agencies.

The use of Therapeutic Performance Mapping System© allows Anaxomics' customers to find new potential cures for Alzheimer Disease.

Link to Reprofiling in Alzheimer's Disease Video

Our company's locations

Lausanne

Mr Jaccard, Rte de Vallaire 5 B
1025 CH-Saint-Sulpice, Vaud
See it on Google maps
Phone: +34 93 451 67 17
info@anaxomics.com

Barcelona

c/Balmes, 89, 4º, 2ª
08008, Barcelona
See it on Google maps
Phone: +34 93 451 67 17
info@anaxomics.com

Boston

8, Faneuil Hall Marketplace
02109 Boston, Massachusetts
See it on Google maps
Phone: +34 93 451 67 17
info@anaxomics.com

Anaxomics Offices Map
Anaxomics on LinkedIn
make your own beats by dre